Abstract
Background Breast cancer is a leading cause of cancer-related death in women. Classifications of pathological images are important for its diagnosis and prognosis. However, the existing computational methods can sometimes hardly meet the accuracy requirement of clinical applications, due to uneven color distribution and subtle difference in features.
Methods In this study, a novel classification method DeepBC was proposed for classifying the pathological images of breast cancer, based on the deep convolution neural networks. DeepBC integrated Inception, ResNet, and AlexNet, extracted features from images, and classified images of benign and malignant tissues.
Results Additionally, complex tests were performed on the existing benchmark dataset to evaluate the performance of DeepBC. The evaluation results showed that, DeepBC achieved 92% and 96.43% accuracy rates in classifying patients and images, respectively, with the F1-score of 97.38%, which better than the state-of-the-art methods.
Conclusions These findings indicated that, the model had favorable robustness and generalization, and was advantageous in the clinical classifications of breast cancer.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Natural Science Foundation for Talent Introduction Project of Sichuan University of Science and Engineering (award number 2018RCL20, grant recipient WZL).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The BreakHis database used in this project is a public database. We have cited BreakHis' work as required by the owner.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets supporting the conclusions of this article are available at https://github.com/lwzyb/DeepBC.
